Cargando…
Differentiation therapy of myeloid leukemia: four decades of development
Acute myeloid leukemia is characterized by arrested differentiation, and agents that overcome this block are therapeutically useful, as shown by the efficacy of all-trans retinoic acid in acute promyelocytic leukemia. However, the early promise of differentiation therapy did not translate into clini...
Autores principales: | Madan, Vikas, Koeffler, H. Phillip |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776344/ https://www.ncbi.nlm.nih.gov/pubmed/33054125 http://dx.doi.org/10.3324/haematol.2020.262121 |
Ejemplares similares
-
Differentiation Therapy of Acute Myeloid Leukemia
por: Gocek, Elzbieta, et al.
Publicado: (2011) -
Synthesis and Characterization of Novel 2-Amino-Chromene-Nitriles that Target Bcl-2 in Acute Myeloid Leukemia Cell Lines
por: Keerthy, Hosadurga K., et al.
Publicado: (2014) -
The evolution of acute lymphoblastic leukemia research and therapy at MD Anderson over four decades
por: Jabbour, Elias, et al.
Publicado: (2023) -
Targeted Therapy Development in Acute Myeloid Leukemia
por: Totiger, Tulasigeri M., et al.
Publicado: (2023) -
Retinoid Differentiation Therapy for Common Types of Acute Myeloid Leukemia
por: Brown, Geoffrey, et al.
Publicado: (2012)